The Arcutis team is celebrating its IPO in 2020. (courtesy photo) Shares of Westlake Village-based Arcutis Biotherapeutics are up over 100% year-over-year and that trend continued in after-hours trading on Feb. 25 after the company announced its earnings for the fourth quarter and full year 2025. Announced after the markets closed, Arcutis specializes in developing…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
